Osteosarcoma is the most common primary bone malignancy. Recently, studies showed chemokine receptor 4 (CXCR4) played a critical role in osteosarcoma.
Chemokine receptor 4 (CXCR4) is a seven-transmembrane G protein-coupled chemokine receptor and selectively binds the CXC chemokine Stromal Cell-Derived Factor (SDF-1). 7 SDF-1, also knows as CXCL12, is a homeostatic chemokine, whose major function is in regulating hematopoietic cell trafficking and secondary lymphoid tissue architecture. CXCR4 is normally expressed on many cell types including lymphocytes, hematopoietic stem cells, endothelial and epithelial cells. 8 Recently studies have shown that miRNAs play an important role in osteosarcoma and several miRNAs have been identified, such as miR-132, miR-21, miR-215 and miR-143. miR-613 is a newly discovered miRNA and has been reported to function as a tumor suppressor in many cancers. 10 However, its function and molecular basis in the osteosarcoma is incompletely understood.
We have performed miRNA expression profiling in both osteosarcoma tissue and cell line. The results demonstrated that miR-613 expression was significantly downregulated. Over-expression of miR-613 decreased osteosarcoma cells proliferation and induced apoptosis. We also identified CXCR4, which is upregulated in osteosarcoma and plays an important role in the development of lung metastases, as a novel target of miR-613, and upregulation of miR-613 could decrease lung metastases in osteosarcoma. Our data here suggested that miR-613 mediated CXCR4 translational repression may be an additional therapeutic strategy for osteosarcoma.
| MATERIALS AND METHODS

| Patients
All the patients, participants and their guardians were provided written informed consent for this study. In addition, ethical approval was pathologists. To determine plasma concentration of SDF-1 and miRNA in each participant, 5 mL of venous whole blood with EDTAanticoagulated was drawn in totally. Whole blood samples were centrifuged for 10 minutes at 3000 RPM immediately to separate plasma and then stored at −80°till further analysis. Estimation of plasma SDF-1 was carried out by using commercially available ELISA kit (R&D Systems) with a detection range of 156 to 10 000 pg/mL SDF-1. The optical density of the samples was measured by using a microplate reader. No patients received preoperative chemotherapy or radiotherapy before the samples were collected.
| Cell culture and reagents
The cell lines were cultured in DMEM supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin and 100 μg/mL streptomycin. The cultures were incubated at 37°in a standard mixture of 95% air and 5% CO 2 . The media and antibiotics were purchased from Biyuntian(Chian) and FBS was obtained from Gibco (USA). For passaging, cells were detached with trypsin/EDTA and subsequently replanted. The reagents were purchased from Sigma-Aldrich or R&D Systems.
| Real time PCR analysis
Total RNA was extracted from tissues or cells by using TRIzol 
| Migration assay
The migration assay was performed using Transwell assay (Corning 
| Western blot analysis
Tissues or cellular lysates were obtained using RiPA lysis buffer weighed and imaged. Tumor and lung weight was described as the mean ± standard deviation (SD). Lung metastasis was detected by metastatic nodules and hematoxylin and eosin staining.
| Statistical analysis
All of the results are represented as the mean ± (SD). 3 | RESULTS
| Participant characteristics
All the participant characteristics are displayed in Tables 1 and   S1 . The basic characteristics between the osteosarcoma patients and normal healthy controls had no significant difference. The mean patient age was 27.1 ± 14. showed that the patients with high SDF-1 expression had significantly shorter overall survival than those with low SDF-1 expression (P < .01, Figure 1B ). CXCR4 protein expression was examined by IHC and a larger proportion of osteosarcoma samples exhibited CXCR4 in expression (141/211) than of normal control participants (8/42)(P < .05, Figure 1C and Table S1 ). Kaplan-Meier curve analysis demonstrated that CXCR4 positive expression was significantly associated with shorter overall survival ( Figure 1D , P < .05). Based on SDF-1 and CXCR4 expression levels, the osteosarcoma patients were divided into four groups which were SDF-1 F I G U R E 1 A, plasma SDF-1 levels in the osteosarcoma patients (N = 211) significantly elevated than in normal control participants (N = 42) (P < .01). B, Kaplan-Meier curve analysis demonstrated that the patients with high SDF-1 expression (N = 106) had significantly shorter overall survival than those with low SDF-1 expression (N = 105) (P < .01). C, Representative CXCR4 protein expression in osteosarcoma patients examined by IHC (a. negative sample, b. positive sample: a diffuse membrane and cytoplasmic staining of CXCR4 were evident in osteosarcoma tissues). D, Kaplan-Meier survival analysis showed that patients (N = 141) with CXCR4 positive expression were significantly associated with shorter overall survival (P < . /CXCR4 + expression pattern had shortest overall survival time (P < .01) SDF-1 decreased the apoptosis rate while inhibition of CXCR4 by AMD3100 or CXCR4 siRNA induced MG-63 apoptosis.
| miR-613 downregulates CXCR4 to reduce proliferation and induce apoptosis in osteosarcoma
Compared with human fetal osteoblastic hFOB 1.19 cell, the expression level of miR-613 significantly decreased in MG-63 cell line (Figure 3A) . By using Targetscan programs, we predicted CXCR4 was the target gene of miR-613 ( Figure 3B ). To confirm it, luciferase reporter assay showed that miR-613 downregulated CXCR4 by targeting 3′UTR of CXCR4 gene while miR-613 had no effect on mutated CXCR4 gene ( Figure 3C 
| The expression of miR-613 and its prognostic value in osteosarcoma
The tissue expression level of miR-613 was examined in osteosarcoma patients and healthy controls using RT-PCR. As shown in Figure 5A , significantly lower expression of miR-613 was observed in the osteosarcoma patients than in controls, especially in CXCR4 positive group(P < .05). According to the median value of miR-613 expression, the osteosarcoma patients were divided into high and low miR-613 expression. Kaplan-Meier curve analysis showed that the patients with low miR-613 expression had significantly shorter overall survival time than those with high miR-613 expression (P < .01, Figure 5B ).
| DISCUSSION
Osteosarcoma is a highly aggressive tumor and usually arise in long bones. Studies have demonstrated that osteosarcoma may be involved in genetic and molecular alterations which affect osteoblast differentiation.
14,15 SDF-1/CXCR4 axis was found to play important roles in almost all malignancies including osteosarcoma. 16 ,17 miRNAs play critical roles in regulating cell processes and may function as oncogenes or tumor suppressors to regulate gene and protein expression. Research data suggested that several miRNAs were involved in the pathogenesis of osteosarcoma and had the potential for development in disease diagnostics and therapeutics. 18 In this study, we confirmed that SDF-1/CXCR4 axis played important roles in osteosarcoma and identified miR-613 targeted 3′UTR of CXCR4 mRNA, which also involved in the pathogenesis of osteosarcoma including lung metastases.
In line with earlier reports, we also observed an increase in SDF-1 and CXCR4 expressions in osteosarcoma patients. 16, 17, 19 Although different studies revealed that both SDF-1 and CXCR4 were prognostic markers for osteosarcoma respectively, there is no study evaluating the combination role of SDF-1 and CXCR4 in prognostic value. Our data showed that the SDF-1 high /CXCR4 + group had the shortest overall survival time as previously expected. Western blot results showed that CXCR4 protein expression in osteosarcoma cells were significantly higher that in hFOB 1.19 cell. E. Addition of SDF-1 (0.1 μg/mL) could increase MG-63 cell proliferation significantly (P < .01). F. CXCR4 specific pharmaceutical inhibitor AMD3100 and genetic inhibitor CXCR4 siRNA dramatically reduced MG-63 proliferation induced by SDF-1(P < .01). G, AMD3100 and CXCR4 siRNA significantly decreased MG-63 cell migration which could be promoted by SDF-1(P < .01). H&I. Flow cytometry results indicted that SDF-1 decreased the apoptosis rate (Q2 and Q3) while inhibition of CXCR4 by AMD3100 or CXCR4 siRNA induced MG-63 apoptosis (P < .01). J. Cleaved Caspase 3 and Cleaved PARP significantly increased in MG-63 cell treated with AMD3100 and CXCR4 miRNA F I G U R E 3 A, The expression level of miR-613 significantly lower in MG-63 cell line (P < .01). B, Targetscan programs predicted CXCR4 was the target gene of miR-613. C, Luciferase reporter assay demonstrated that miR-613 downregulated wild type CXCR4(P < .01) while had no effect on mutated CXCR4 gene (P > .05). CXCR mRNA (D) and protein (E) levels were dramatically downregulated by miR-613 mimics and upregulated by miR-613 inhibitor (P < .01). F, miR-613 mimics decreased MG-63 proliferation while miR-613 inhibitor increased MG-63 proliferation significantly (P < .01). G, miR-613 mimics decreased MG-63 migration (P < .01) while miR-613 inhibitor increased MG-63 migration (P < .01) significantly. H&I, Flow cytometry results showed that miR-613 mimics increased the apoptosis rate (Q2 and Q3) (P < .01) while miR-613 decreased the apoptosis rate (P < .01). J, Cleaved Caspase 3 and Cleaved PARP significantly increased in MG-63 cell treated with miR-613 mimics (P < .01) while had no significantly different in MG-63 cell treated with miR-613 inhibitor F I G U R E 4 A, Nude mice injected with osteosarcoma cells were treated for miR-613 agomir, negative control and miR-613 antagomir (representative mice were presented, N = 5/group). B, in situ osteosarcoma cancer was isolated and representative cancer tissues were presented (N = 5/group). C, smaller weight in situ osteosarcoma cancer was detected in agomir-treated nude mice while larger in antagomirtreated nude mice (N = 5/group) (P < .01). D, RT-PCR results showed miR-613 in agomir was significantly increased while decreased in antagomir group (P < .01). E, Western blot results showed that the CXCR4 protein expression elevated in antagomir group and reduced in agomir group (N = 5/group). F, Representative lung tissues were presented. Less metastases (white nodules) was observed in agomir group while more metastases in antagomir-treated group (N = 5/group). G, HE staining results of lung tissues showed that more nodules and massive substitution in antagomir-treated group while less in agomir-treated group (N = 5/group) Since the discovery of the first miRNA in 1993, 22 more than 1000 miRNAs have been found in the human genome. 23, 24 They have the potential to regulate various critical biological processes including proliferation, migration and apoptosis of different kind of cancer cells. 25, 26 Previous studies have indicated that many miRNAs, such as miR- CXCR4 is a well-studied G-protein coupled chemokine receptor and commonly expressed on lots of cell types including osteosarcoma cells. 34 The binding of SDF-1 to CXCR4 results in divergent downstream signaling pathways that mediate cell proliferation, migration and apoptosis. 35 Many experiments have proven that the expression level of SDF-1 and CXCR4 significantly increased in a wide variety of malignancies. 9 High level of CXCR4 has been shown to correlate with the presence of metastatic disease in different cancers, such as breast, 36 prostate, 37 lung 38 and melanoma. 39 Although the SDF-1/ CXCR4 axis appears to affect metastasis in numerous cancers, its mechanism in osteosarcoma remains unclear. Perissinotto's study
showed that high SDF-1 concentration contributed to the osteosarcoma metastatic development into the lung and inhibiting the SDF-1/ CXCR4 pathway by small-molecule inhibitors or anti-CXCR4 antibodies, T134 peptide, might prevent the dissemination of osteosarcoma cells. 17 Liao et al 20 found that blocking CXCR4 by AMD3100 could reduce primary tumor growth and lung metastasis. And this effect was regulated through the JNK and AKT pathways, not the p38 or 
